| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 06/07/2007 | CA2631232A1 Novel vinylogous acids derivatives |
| 06/07/2007 | CA2629037A1 Compositions comprising a combination of ccr5 and cxcr4 antagonists |
| 06/06/2007 | EP1793000A1 Transgenically produced non-secreted proteins |
| 06/06/2007 | EP1792998A2 An unusual retrotransposon from the yeast Candida albicans |
| 06/06/2007 | EP1792991A1 Human CTLA-4 antibodies and their uses |
| 06/06/2007 | EP1792910A2 Effectors of dipeptidyl peptidase IV for topical use |
| 06/06/2007 | EP1792628A1 Vaccines |
| 06/06/2007 | EP1792627A1 Modulation of the immune response by administration of intralymphatic transduction allergen (ITAG-)-molecules |
| 06/06/2007 | EP1792537A1 Method of constructing clone mammal |
| 06/06/2007 | EP1791873A1 New polymorphic form of inulin and uses thereof |
| 06/06/2007 | EP1791870A1 Virus-like particles comprising a fusion protein of the coat protein of ap205 and an antigenic polypeptide |
| 06/06/2007 | EP1791865A2 Cells expressing a modified t cell receptor |
| 06/06/2007 | EP1791832A1 4-(heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists |
| 06/06/2007 | EP1791830A1 Diaminotriazole compounds useful as protein kinase inhibitors |
| 06/06/2007 | EP1791552A2 Protein a compositions and methods of use |
| 06/06/2007 | EP1791535A2 Novel tellurium compounds and their use as immunomodulators |
| 06/06/2007 | EP1791526A2 Pharmaceutical multiparticulate composition comprising mycophenolic acid or mycophenolate sodium and combination compositions with rapamycin |
| 06/06/2007 | EP1487998B1 Methods for diagnosing and treating schizophrenia |
| 06/06/2007 | EP1406660B1 Combination of an aldosterone receptor antagonist and an hmg coa reductase inhibitor |
| 06/06/2007 | EP1392254B1 Micellar drug delivery systems for hydrophobic drugs |
| 06/06/2007 | EP1363874B1 Tryptase inhibitors |
| 06/06/2007 | EP1158958B1 Improved powdery pharmaceutical compositions for inhalation |
| 06/06/2007 | EP0954317B1 Use of 7 apha-substituted steroids to treat neuropsychiatric disorders |
| 06/06/2007 | EP0886679B1 Parapoxviruses containing foreign dna, their production and their use in vaccines |
| 06/06/2007 | CN1976950A Anti-CD38 human antibodies and uses therefor. |
| 06/06/2007 | CN1976934A Alkyl substituted indoloquinoxalines |
| 06/06/2007 | CN1976919A Pyrrole inhibitors of ERK protein kinase, synthesis thereof and intermediates thereto |
| 06/06/2007 | CN1976918A 4,5-disubstituted-2-aryl pyrimidines |
| 06/06/2007 | CN1974596A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 06/06/2007 | CN1973898A P28 molecule or medicinal preparation containing gene thereof |
| 06/06/2007 | CN1973890A Medicine prepn for promoting intelligence growth and nourishing brain and its prepn process |
| 06/06/2007 | CN1973885A Shenjing capsule and shenjing oral liquid |
| 06/06/2007 | CN1973874A Qizhen capsule and Qizhen oral liquid for strengthening immunity |
| 06/06/2007 | CN1973850A Medicine composition for treating allergic rhinitis and its prepn process |
| 06/06/2007 | CN1973848A Application of Wushan epimedium fotal phenolic acid in medicine and health food |
| 06/06/2007 | CN1973687A Health oyster-turtle powder |
| 06/06/2007 | CN1973681A Technological process of producing oat diet fiber and nutritious powder with oat bran |
| 06/06/2007 | CN1973651A Vanilla-asiatic centella tea and its prepn process |
| 06/06/2007 | CN1319991C Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides |
| 06/06/2007 | CN1319981C Preparation process of plantago fotal glycocide and its application in medicine |
| 06/06/2007 | CN1319973C Piperidine derivatives |
| 06/06/2007 | CN1319968C Compositions useful as inhibitors of GSK-3 |
| 06/06/2007 | CN1319593C Oral enteric-coated microsphere of Thymosin and preparation thereof |
| 06/06/2007 | CN1319538C Preparation method of Astragaloside material medicine, the material medicine and preparation |
| 06/05/2007 | USRE39681 1-(4-sulfamyaryl)-3-substituted-5-aryl-2-pyrazolines and inhibitors of cyclooxygenase-2 |
| 06/05/2007 | US7227038 Adamantane derivatives, processes for their preparation and pharmaceutical composition containing them |
| 06/05/2007 | US7227020 protein kinase inhibitors; asthma, psoriasis, antiinflammatory agents; inflammatory bowel disorders |
| 06/05/2007 | US7227002 Human antibodies that bind human 17-A1/EpCAM tumor antigen |
| 06/05/2007 | US7226998 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation |
| 06/05/2007 | US7226934 Having antiallergic and anti-inflammatory effects while being devoid of the severe dose-limiting sedative side effects of ketotifen |
| 06/05/2007 | US7226627 Grapeseed, cold-pressed grape oil, crushed grape and grape flour |
| 06/05/2007 | US7226614 segmented; sustained release; for treatment of allergies |
| 06/05/2007 | US7226595 Conjugated antigen for use as tool in the treatment of cancer |
| 06/05/2007 | CA2411671C Inhibitors of alpha l beta 2 mediated cell adhesion |
| 06/02/2007 | CA2632245A1 Novel plant virus particles and methods of inactivation thereof |
| 05/31/2007 | WO2007062175A2 Spiro-substituted tricyclic heterocycles cxcr3 antagonists |
| 05/31/2007 | WO2007062043A1 Method of activating murine toll-like receptor 8 |
| 05/31/2007 | WO2007061102A1 Fermentation and culture method, fermented plant extract, composition containing fermented plant extract, method for producing lipopolysaccharide and lipopolysaccharide |
| 05/31/2007 | WO2007061074A1 Novel bisboron compound |
| 05/31/2007 | WO2007060918A1 Novel memory ctl induction potentiator |
| 05/31/2007 | WO2007060864A1 Antibody-producing precursor b cell whose growth and differentiation can be controlled |
| 05/31/2007 | WO2007060802A1 Solid pharmaceutical preparation and pharmaceutical preparation composition |
| 05/31/2007 | WO2007060747A1 Galectin-9 induction factor |
| 05/31/2007 | WO2007060725A1 Recombinant polyvalent vaccine |
| 05/31/2007 | WO2007060652A1 Beta glycolipids as immuno-modulators |
| 05/31/2007 | WO2007060626A1 Novel thiophene derivatives |
| 05/31/2007 | WO2007037544A9 Development of method for screening of compound capable of improving the production of regulatory t cell, and method for production of regulatory t cell using immunosuppressive macrolide antibiotic |
| 05/31/2007 | WO2007007145A3 Use of anti-madcam antibodies for the treatment of coeliac disease and tropical sprue |
| 05/31/2007 | WO2007006041A3 Imaging and therapeutic method using monocytes |
| 05/31/2007 | WO2006131347A3 Use of the ides proteinase (from s. pyogenes) for treating autoimmune diseases and graft rejection |
| 05/31/2007 | WO2006127900A3 Tl1a in the treatment of disease |
| 05/31/2007 | WO2006116458A3 Modified oligoribonucleotide analogs with enhances immunostimulatory activity |
| 05/31/2007 | WO2006074370A3 Agonists and antagonists of tnfrii/cd120b for treatment of immune-related diseases |
| 05/31/2007 | WO2006015318A3 Antibody conjugated to a drug moiety via a poptidic linker |
| 05/31/2007 | US20070123570 Phosphodiesterase 4 inhibitors, including aminoindazole and aminobenzofuran analogs |
| 05/31/2007 | US20070123532 Piperazine derivatives |
| 05/31/2007 | US20070123530 e.g. (2-chloropyrimidin-4-yl)-(4-ethyl-3H-thiazol-2ylidene)-acetonitrile,[4-(4-chlorophenyl)-1,3-thiazol-2(3H)-ylidene](2-chloropyrimidin-4-yl)acetonitrile; Jun N-terminal kinase and Glycogen Synthase Kinase 3 inhibitor; antidiabetic, antiinflammatory, anticarcinogenic agent; neurodegenerative diseases |
| 05/31/2007 | US20070123459 IL-17 like molecules and uses thereof |
| 05/31/2007 | US20070123452 Method of selecting novel immunosuppressant |
| 05/31/2007 | US20070122423 Derp1 and proderp1 allergen derivatives |
| 05/31/2007 | US20070122418 Compositions and methods for the pulmonary delivery of aerosolized medicaments |
| 05/31/2007 | US20070122417 Immunotherapy method |
| 05/31/2007 | US20070122403 Molecules with extended half-lives, compositions and uses thereof |
| 05/31/2007 | US20070122354 possess superior aerosol properties, even in the absence of stabilizing carriers or excipients; inhalants; when administered to the deep lung, are useful for treating allergic diseases, such as asthma, atopy, and atopic dermatitis |
| 05/31/2007 | DE102005057421A1 New heteroaromatic sulfonamide prodrugs, useful for delivering e.g. antimalarials and steroids for e.g. fertility control or hormone replacement therapy |
| 05/31/2007 | DE102005057408A1 New sulfamoylsulfonate prodrugs e.g. useful for protecting red blood cells from attack by parasites or for hormone replacement therapy, female fertility control or treating hormone-associated diseases |
| 05/31/2007 | DE102005057225A1 New 8-beta-substituted estratriene derivatives esterified with a sulfamoylphenyl-substituted acid residue, are prodrugs useful as carboanhydrase inhibitors for treating estrogen deficiency disorders |
| 05/31/2007 | DE102005057224A1 New 9-alpha substituted estratriene derivatives esterified with a sulfamoylphenyl-substituted acid residue, are prodrugs useful as carboanhydrase inhibitors for treating estrogen deficiency disorders |
| 05/31/2007 | CA2631017A1 Bisboron compounds for use as intracellular calcium concentration increase inhibitors |
| 05/31/2007 | CA2631015A1 Human monoclonal antibody human cd134 (ox40) and methods of making and using same |
| 05/31/2007 | CA2630935A1 Beta glycolipids as immuno-modulators |
| 05/31/2007 | CA2630770A1 Recombinant polyvalent vaccine |
| 05/31/2007 | CA2630738A1 Immunostimulatory oligoribonucleotides |
| 05/31/2007 | CA2630699A1 Substituted 5-heteroaryl-1-phenyl-pyrazole cannabinoid modulators |
| 05/31/2007 | CA2629122A1 Novel thiophene derivatives |
| 05/30/2007 | EP1790725A2 Proteins named after FCTRX and nucleic acids encoding same |
| 05/30/2007 | EP1790715A1 Method for stabilizing the antiallergic activity of lactic acid bacteria aganst high-temperature treatment, stabilized compositions, and food and drink |
| 05/30/2007 | EP1790655A2 Biologically active peptides |
| 05/30/2007 | EP1790652A1 Polycyclic guanine phosphodiesterase V inhibitors |
| 05/30/2007 | EP1790651A1 A1 adenosine receptor antagonists |